VRTX vs GILD
Vertex Pharmaceuticals vs Gilead Sciences — AI-powered side-by-side comparison
| Metric | VRTX | GILD |
|---|---|---|
| AI Score | 55 | 66 |
| Price | $485.36 | $129.81 |
| P/E Ratio | 30.05× | 18.11× |
| ROE | 23.9% | 42.2% |
| Revenue Growth YoY | 10.1% | 3.5% |
| Gross Margin | 86.2% | 79.3% |
| Debt / Equity | 0.01× | 1.10× |
| Dividend Yield | — | 2.4% |
| RSI (14) | 43.8 | 49.2 |
| Beta | 0.2937 | 0.3411 |
| Expected Upside | +0.4% | +21.1% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
VRTX Full Analysis
GILD Full Analysis